{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:38:28Z","timestamp":1783615108237,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006393","name":"Universidad de Granada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.gastrohep.2025.502440","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T20:51:44Z","timestamp":1743713504000},"page":"502440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Desaf\u00edos en la adherencia a STRIDE-II: perspectivas de gastroenter\u00f3logos y pacientes con enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4947-2024","authenticated-orcid":false,"given":"Francisca","family":"Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-5266","authenticated-orcid":false,"given":"Karin","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-1851","authenticated-orcid":false,"given":"Paulina","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-8224","authenticated-orcid":false,"given":"Lilian","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-181X","authenticated-orcid":false,"given":"Andrea","family":"C\u00f3rdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9991-9616","authenticated-orcid":false,"given":"Gonzalo","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-3050","authenticated-orcid":false,"given":"Pamela","family":"San Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5854-0526","authenticated-orcid":false,"given":"Rodrigo","family":"Quera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502440_bib0215","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0220","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0225","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3748\/wjg.v24.i22.2363","article-title":"Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?","volume":"24","author":"Strohl","year":"2018","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0235","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00535-012-0721-x","article-title":"Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: A prospective cohort study","volume":"48","author":"Kawakami","year":"2013","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0240","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.3748\/wjg.v23.i41.7387","article-title":"Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease","volume":"23","author":"Kostas","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0245","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00535-023-02013-7","article-title":"Correlation of mucosal healing endpoints with long\/term clinical and patients\/reported outcomes in ulcerative colitis","volume":"58","author":"Parkes","year":"2023","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0250","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: Recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0255","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: Terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0265","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0270","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review","volume":"105","author":"Jackson","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0275","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17474124.2021.1898944","article-title":"Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration","volume":"15","author":"Denesh","year":"2021","journal-title":"Expet Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0280","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.pec.2021.10.017","article-title":"Interventions to improve medication adherence in inflammatory bowel disease: A systematic review","volume":"105","author":"Gohil","year":"2022","journal-title":"Patient Educ Couns."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0285","first-page":"716","article-title":"Corticosteroids in inflammatory bowel disease: Are they still a therapeutic option?","volume":"46","author":"Quera","year":"2023","journal-title":"J Gastroenterol Hepatol (Engl Ed)."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jgh.13923","article-title":"Limited uptake of ulcerative colitis \u00abtreat-to-target\u00bb recommendations in real-world practice","volume":"33","author":"Bryant","year":"2018","journal-title":"Gastroenterol Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2025.502440_bib0295","doi-asserted-by":"crossref","first-page":"i1190","DOI":"10.1093\/ecco-jcc\/jjae190.0772","article-title":"P0598 Feasibility and limitations in adopting treat-to-target approach in inflammatory bowel diseases (IBD): Real-life scenario","volume":"19","author":"Harindranath","year":"2025","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00004836-198604000-00010","article-title":"Use of an intravenous steroid regimen in the treatment of acute Crohn's disease","volume":"8","author":"Shepherd","year":"1986","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0310","first-page":"CD000543","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","volume":"4","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0315","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1590-8658(03)00372-4","article-title":"Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: A randomised, investigator-blind study","volume":"35","author":"Ardizzone","year":"2003","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0320","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0140-6736(00)02871-3","article-title":"Mechanisms in failure of infliximab for Crohn's disease","volume":"356","author":"Nikolaus","year":"2000","journal-title":"Lancet."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2013.05.048","article-title":"Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis","volume":"146","author":"Sandborn","year":"2014","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0330","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cgh.2022.07.027","article-title":"Prognostic value of fecal calprotectin to inform treat-to-target monitoring in ulcerative colitis","volume":"21","author":"Dulai","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0335","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/07853890.2022.2082518","volume":"54","author":"Grgi\u0107","year":"2022","journal-title":"Ann Med."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: A diagnostic accuracy meta-analysis","volume":"27","author":"Rokkas","year":"2018","journal-title":"J Gastrointestin Liver Dis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.gastrohep.2018.05.029","article-title":"Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease","volume":"41","author":"Guardiola","year":"2018","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0350","first-page":"508","article-title":"Objective disease monitoring strategies from a tertiary inflammatory bowel disease center in Hungary","volume":"34","author":"Lontai","year":"2023","journal-title":"Turk J Gastroenterol."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2025.502440_bib0355","first-page":"i608","article-title":"Outcomes of endoscopic and histologic remission in ulcerative colitis under advanced therapy","volume":"18","author":"Rodrigues","year":"2024","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0360","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-023-08220-9","article-title":"IBD-PODCAST Spain: A close look at current daily clinical practice in IBD management","author":"Vega","year":"2024","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0365","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.14309\/ajg.0000000000002294","article-title":"Utilization of treat-to-target monitoring colonoscopy after treatment initiation in the US-based study of a prospective adult research cohort with inflammatory bowel disease","volume":"118","author":"Yang","year":"2023","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0370","first-page":"502232","article-title":"Evaluation of the sensitivity and specificity of sigmoidoscopy in comparison to colonoscopy regarding the detection of intestinal inflammatory activity in the follow-up of patients with ulcerative colitis","volume":"17","author":"Calder\u00f3n","year":"2024","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0375","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3748\/wjg.v29.i15.2272","article-title":"Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making","volume":"29","author":"Dolinger","year":"2023","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0380","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cgh.2024.04.039","article-title":"AGA clinical practice update on the role of intestinal ultrasound in inflammatory bowel disease: Commentary","volume":"22","author":"Chavannes","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3748\/wjg.v30.i1.50","article-title":"Treat to target in Crohn's disease: A practical guide for clinicians","volume":"30","author":"Srinivasan","year":"2024","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0390","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/flgastro-2019-101366","article-title":"Acceptability of a \u2018treat to target\u2019 approach in inflammatory bowel disease to patients in clinical remission","volume":"12","author":"Selinger","year":"2021","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0395","doi-asserted-by":"crossref","first-page":"otae055","DOI":"10.1093\/crocol\/otae055","article-title":"Clinical approach to STRIDE-II in real-life settings: analysis and practical recommendations","volume":"6","author":"Ricart","year":"2024","journal-title":"Crohns Colitis 360"},{"key":"10.1016\/j.gastrohep.2025.502440_bib0400","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jgh.13923","article-title":"Limited uptake of ulcerative colitis \u2018treat-to-target\u2019 recommendations in real-world practice","volume":"33","author":"Bryant","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10754-012-9105-2","article-title":"Public versus private: Evidence on health insurance selection","volume":"12","author":"Pardo","year":"2012","journal-title":"Int J Health Care Finance Econ."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0410","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healthpol.2017.11.007","article-title":"Out-of-pocket health expenditure differences in Chile: Insurance performance or selection?","volume":"122","author":"Villalobos Dintrans","year":"2018","journal-title":"Health Policy."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0415","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ibd\/izad159","article-title":"Clearance as a new outcome in ulcerative colitis: A systematic review and expert consensus","volume":"30","author":"D\u2019Amico","year":"2024","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2025.502440_bib0420","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2468-1253(21)00096-0","article-title":"Transmural healing as a therapeutic goal in Crohn's disease: A systematic review","volume":"6","author":"Geyl","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525001050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525001050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:11:56Z","timestamp":1763863916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0210570525001050"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502440","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desaf\u00edos en la adherencia a STRIDE-II: perspectivas de gastroenter\u00f3logos y pacientes con enfermedad inflamatoria intestinal","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502440"}}